» Articles » PMID: 34063514

Microaneurysm Turnover in Mild Non-Proliferative Diabetic Retinopathy is Associated with Progression and Development of Vision-Threatening Complications: A 5-Year Longitudinal Study

Overview
Journal J Clin Med
Specialty General Medicine
Date 2021 Jun 2
PMID 34063514
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Analysis of retinal microaneurysm turnover (MAT) has been previously shown to contribute to the identification of eyes at risk of developing clinically significant complications associated with diabetic retinopathy (DR). We propose to further characterize MAT as a predictive biomarker of DR progression and development of vision-threatening complications.

Methods: 212 individuals with type 2 diabetes (T2D; ETDRS grades 20 and 35) were evaluated annually in a 5-year prospective, longitudinal study, by color fundus photography and optical coherence tomography. Endpoints were diabetic macular edema (DME) or proliferative retinopathy (PDR). MAT analysis included determination of MA formation and disappearance rates, automatically assessed using the RetMarkerDR. Retinopathy severity progression was evaluated using step increases in ETDRS severity levels.

Results: Of the 212 individuals, 172 completed the 5-year follow-up study or developed an endpoint (n = 27). MAT calculated at 1 year showed a significant difference between groups of endpoint developments ( = 0.018), particularly MA disappearance rate ( = 0.007). MAT also showed a significant difference between eyes with different ETDRS severity progression in the 5-year period ( = 0.035).

Conclusions: MAT is an indicator of the development of DME and/or PDR as well as of DR severity progression in T2D individuals with mild retinopathy.

Citing Articles

Use of artificial intelligence with retinal imaging in screening for diabetes-associated complications: systematic review.

Yang Q, Bee Y, Lim C, Sabanayagam C, Yim-Lui Cheung C, Wong T EClinicalMedicine. 2025; 81:103089.

PMID: 40052065 PMC: 11883405. DOI: 10.1016/j.eclinm.2025.103089.


Characteristics of Microaneurysm Size in Residual Edema After Intravitreal Injection of Faricimab for Diabetic Macular Edema.

Yamada Y, Takamura Y, Morioka M, Oshima H, Gozawa M, Matsumura T J Clin Med. 2025; 13(24.

PMID: 39768761 PMC: 11677900. DOI: 10.3390/jcm13247839.


Progression of Capillary Hypoperfusion in Advanced Stages of Nonproliferative Diabetic Retinopathy: 6-month Analysis of RICHARD Study.

Marques I, Reste-Ferreira D, Santos T, Mendes L, Martinho A, Yamaguchi T Ophthalmol Sci. 2024; 5(2):100632.

PMID: 39639890 PMC: 11616502. DOI: 10.1016/j.xops.2024.100632.


Correlation between Topographic Vessel Density and Retinal Thickness Changes in Patients with Diabetic Macular Edema Treated with Anti-VEGF Therapy: Is It a Suitable OCTA Biomarker?.

Santamaria J, Caminal J, Cobos E, Biarnes M, Rodriguez-Leor R, Morwani R J Pers Med. 2023; 13(12).

PMID: 38138945 PMC: 10744775. DOI: 10.3390/jpm13121718.


The relationship of diabetic retinopathy severity scales with frequency and surface area of diabetic retinopathy lesions.

Esmaeilkhanian H, Liu H, Fasih-Ahmed S, Gnanaraj R, Verma A, Oncel D Graefes Arch Clin Exp Ophthalmol. 2023; 261(11):3165-3176.

PMID: 37392262 PMC: 10587246. DOI: 10.1007/s00417-023-06145-7.


References
1.
Sjolie A, Klein R, Porta M, Orchard T, Fuller J, Parving H . Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme. Diabet Med. 2011; 28(3):345-51. DOI: 10.1111/j.1464-5491.2010.03210.x. View

2.
Tan B, Chua J, Lin E, Cheng J, Gan A, Yao X . Quantitative Microvascular Analysis With Wide-Field Optical Coherence Tomography Angiography in Eyes With Diabetic Retinopathy. JAMA Netw Open. 2020; 3(1):e1919469. PMC: 6991275. DOI: 10.1001/jamanetworkopen.2019.19469. View

3.
Martinho A, Marques I, Messias A, Santos T, Madeira M, Sousa D . Ocular and Systemic Risk Markers for Development of Macular Edema and Proliferative Retinopathy in Type 2 Diabetes: A 5-Year Longitudinal Study. Diabetes Care. 2020; 44(1):e12-e14. PMC: 7783945. DOI: 10.2337/dc20-1125. View

4.
. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991; 98(5 Suppl):823-33. View

5.
Cunha-Vaz J . A Central Role for Ischemia and OCTA Metrics to Follow DR Progression. J Clin Med. 2021; 10(9). PMC: 8122480. DOI: 10.3390/jcm10091821. View